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Wide-spectrum biomimetic antimicrobial systems
Abstract
Antimicrobial peptides (AMPs) are effective components of the host immune response and are widely
distributed throughout nature. Recently, nontoxic antimicrobial polymers that mimic the structures of
naturally occurring AMPs have been designed and are under development commercially as novel
therapeutics. These compounds have several potential advantages over natural AMPs, including greater
stability and reduced immunogenicity compared to natural peptides, relatively simple and scalable syntheses
and the ability to tailor or “fine tune” their activities through combinatorial approaches. In previous work, we
demonstrated the utility of certain generally regarded as safe (GRAS) flavorant and aroma compounds as
enhancers of uptake and activity of clinically important antibiotics (Brehm-Stecher & Johnson, 2003). Here,
we have extended this approach to include enhancement of biomimetic antimicrobial polymers. Three low
molecular weight (<1000 >D), broad-spectrum arylamide polymers (PolyMedix, Inc., Radnor, PA) were
examined for their antimicrobial activities against gram-negative bacteria, gram-positive bacteria, yeast and
filamentous fungi, both alone and when co-administered with sesquiterpenoid enhancers. Assay formats
included disk diffusion, automated turbidimetry, time course (kinetic) plating of antimicrobial-treated cell
suspensions, outer membrane assays with 1-N-phenylnaphthylamine (NPN) and transmission electron
microscopy (TEM). Although results differed according to the polymer and test organism used, treatments
containing sesquiterpenoids were marked by either increased ZOIs, decreased MICs or more rapid
inactivation when compared with polymer-only treatments. Antimicrobial activity, expressed as decimal
reduction times (D-value), showed that after 5 min, the combination of sesquiterpenoid and polymer was
significantly different from the controls (p < 0.05) with a D-value of 3.92 min when incubated with
Escherichia coli ATCC 25922. Collectively, our results indicate that the combination of sesquiterpenoid-
enhancing agents with biomimetic antimicrobial polymers shows promise for the development of new, faster-
acting and more broadly effective antimicrobial therapies.
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ABSTRACT
Antimicrobial peptides (AMPs) are effective components of the
host immune response and are widely distributed throughout
nature. Recently, nontoxic antimicrobial polymers that mimic the
structures of naturally occurring AMPs have been designed and
are under development commercially as novel therapeutics. These
compounds have several potential advantages over natural AMPs,
including greater stability and reduced immunogenicity com-
pared to natural peptides, relatively simple and scalable syntheses
and the ability to tailor or “fine tune” their activities through
combinatorial approaches. In previous work, we demonstrated
the utility of certain generally regarded as safe (GRAS) flavorant
and aroma compounds as enhancers of uptake and activity of
clinically important antibiotics (Brehm-Stecher & Johnson, 2003).
Here, we have extended this approach to include enhancement
of biomimetic antimicrobial polymers. Three low molecular
weight (<1000 D), broad-spectrum arylamide polymers (Poly-
Medix, Inc., Radnor, PA) were examined for their antimicrobial
activities against gram-negative bacteria, gram-positive bacteria,
yeast and filamentous fungi, both alone and when co-adminis-
tered with sesquiterpenoid enhancers. Assay formats included
disk diffusion, automated turbidimetry, time course (kinetic)
plating of antimicrobial-treated cell suspensions, outermembrane
assays with 1-N-phenylnaphthylamine (NPN) and transmission
electron microscopy (TEM). Although results differed according
to the polymer and test organism used, treatments containing
sesquiterpenoids were marked by either increased ZOIs,
decreased MICs or more rapid inactivation when compared with
polymer-only treatments. Antimicrobial activity, expressed as
decimal reduction times (D-value), showed that after 5 min, the
combination of sesquiterpenoid and polymer was significantly
different from the controls (p < 0.05) with a D-value of
3.92 min when incubated with Escherichia coli ATCC 25922.
Collectively, our results indicate that the combination of sesqui-
terpenoid-enhancing agents with biomimetic antimicrobial poly-
mers shows promise for the development of new, faster-acting
and more broadly effective antimicrobial therapies.
INTRODUCTION
The recent discovery of the widespread distribution of
antimicrobial peptides (AMPs) in multicellular organisms
and their essential role in host defense mechanisms has
uncovered novel possibilities for therapeutics. Despite the
sequence-based diversity of these peptides among organisms,
recent work has revealed surprising similarities between
conserved structures and antimicrobial function. Many of the
peptides yielding substantial antimicrobial activity share
similar “facially amphiphilic” structures (Hancock & Rozek,
2002; Yeaman & Yount, 2003).
Antimicrobial activity depends largely upon the interaction
with the negatively charged bacterial surface, which is the
initial target for peptide contact, leading to an induction of
amphiphilic structures formation. In gram-negative bacteria,
the peptides first interact with the outer membranes that are
rich in lipopolysaccharides (LPS), whereas in gram-positive
bacteria they transverse the negatively charged peptidoglycan
layer rich in teichoic and teichuronic acids (Shai, 2002;
Yeaman & Yount, 2003; Zasloff, 2002). The outer membrane
present in gram-negative bacteria results in an additional
permeability barrier that may impart increased resistance to
certain antimicrobials. The basis for the integrity of the outer
membrane is a result of the LPS surface which can potentially
bind compounds and decrease their permeability into the
interior of the cell (Vaara, 1992). This decreased entrance into
the cell has been exploited by knowledge as to the action of
AMPs. These unifying structure–function relationships among
AMPs have spurred the development of synthetic mimics of
these natural peptides in polymeric and small molecule forms.
Recently, de novo design of facially amphiphilic biomimetic
arylamide polymers has been created that shows antimicro-
bial activity against a range of bacteria based on hydrophobi-
city and charge of the side chains (Tew et al., 2002).
Polymethacrylate derivatives have also been designed and
evaluated for key biological properties that impact antimicro-
bial activity therefore allowing for the design of synthetic
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polymers that are inexpensive to prepare (Kuroda & DeGrado,
2005). This highlights one of the advantages of biomimetic
polymers over natural peptides, including their lower cost
of production and the ability to scale synthesis to industri-
ally relevant production outputs. The insights gained from
studies on AMPs may provide new strategies and templates for
the development and design of novel biomimetics, and they may
be used in therapeutic, pharmaceutical, and food applications.
As these mimics target the cell membrane (a highly conserved
target), widespread microbial resistance is not expected to
develop toward these compounds. This feature is important
due to the increasing instance of bacterial resistance to
conventional antibiotics which typically function by inhibiting
key bacterial enzymes. Bacteria can evade these mechanisms
and develop resistance; however, targeting of central struc-
tural features by AMPs makes them more potent due to the
decreased potential for developed resistance (Lockwood &
Mayo, 2003). In addition, the ability of these mimics to exploit
a separate pathway for antimicrobial or antibiotic uptake
allows for their effectiveness against a broad spectrum of
microorganisms, including gram-negative bacteria and fungi.
Traditional antibiotics typically have a limited spectrum of
activity that decreases their potential range for applications,
especially relating to the additional selectivity barrier inherent
in gram-negative bacteria (Hancock, 1997, 2001; Hancock &
Rozek, 2002; Zasloff, 2002). By targeting the membrane
instead of specific metabolic pathways or enzymes, resistance
issues may be avoided, and the potential for an increased
antimicrobial spectrum of activity may be created.
Although these novel biomimetics have desirable properties,
their antimicrobial activity may still be lessened against gram-
negative bacteria due to the extra outer membrane. However,
certain compounds which alone may be weakly antimicrobial
have been shown to sensitize gram-negative bacteria to
antimicrobial agents by disrupting the outer membrane
(Vaara, 1992). Generally regarded as safe (GRAS) sesquiter-
penoids have previously been shown to be effective antimi-
crobial-enhancing agents, especially for membrane-targeted
antimicrobials (Brehm-Stecher & Johnson, 2003). Because the
biomimetic polymers we are working with act primarily at
microbial membranes, we sought here to combine them with
sesquiterpenoid enhancers in order to create new, high
potency antimicrobial formulations.
MATERIALS AND METHODS
Culture of microorganisms
Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC
29523 were cultured in cation-adjusted Mueller Hinton broth
(MH) (Becton Dickinson and Company, Franklin Lakes, N.J.) as
recommended by CLSI for bacteria that grow aerobically
(M07-A9; CLSI 2012) Trichophyton mentagrophytes ATCC
(9533) was prepared according to CLSI recommendations
for filamentous fungi (M38-A2, CLSI 2008a) with the following
modifications. Fungi were grown on CAMHA at 35°C for 7 days
to produce conidia (Santos et al., 2006). The conidia were
recovered by wetting a loop with Tween 20 and transferring
the loopful of conidia into 5 ml of sterile saline (0.9%). After the
mixture of conidia and hyphal fragments was allowed to settle
for 15–20 min at room temperature, the upper suspension was
transferred to a sterile tube (Espinel-Ingroff & Canton, 2007).
Candida albicans ATCC (90028) was also cultured in RPMI
1640 standard broth according to CLSI guidelines (M27-A3,
CLSI 2008b) overnight at 35°C.
Antimicrobial polymers and sesquiterpenoids
Biomimetic antimicrobial polymers were sourced from Poly-
Medix, Inc. (Radnor, PA). The polymers used were polymetha-
crylates arylamide oligomers (M.W. <2.000) and included
butyl methacrylate (PMX 50001), butyl methacrylate with a
different percent composition of monomers (PMX 50003), and
ethyl methacrylate (PMX 50004). Stock solutions of the
polymers as 10 mg/mL were prepared in 1:1 methanol and
water and stored at 20°C under dry conditions. Sesquiter-
penoids, such as bisabolol, farnesol, and nerolidol, were
sourced from Sigma-Aldrich (St. Louis, MO) with stock
solutions prepared to 10,000 mM in propylene glycol (DOW
Chemical Company, Midland, MI).
Agar diffusion
The endpoint disk diffusion assay was used as a measure to
determine the ability of sesquiterpenoids to sensitize culture
organisms to antimicrobial polymers. Methods were followed as
recommended by CLSI (M2-A9, M07-A9, CLSI 2006, 2012) with
modifications described briefly. Cells were grown overnight (24
h) at 30°C or 35°C in CAMHBwith dilution in neutral phosphate
buffer. An aliquot was combined with a 0.7% Mueller Hinton
agar overlay tempered to 50°C to achieve a final inoculum size
of 106 cfu/mL. Sesquiterpenoid stock solutions in propylene
glycol were added in appropriate combinations to the cell-
overlay mixture to a final concentration of 200 mM. The mixture
was immediately poured over hardened CAMHA in 60 mm
diameter petri dishes. Sterile paper disks (BBL, Becton Dickson
and Company, Franklin Lakes, NJ) were applied an aliquot of the
antimicrobial, placed on the hardened agar overlays, and
incubated at 30°C for 24 h. Diameters of zones (in mm) taken
as a measure of antimicrobial activity were measured from the
bottom of each plate following incubation.
MIC determination
The minimum inhibitory concentrations (MICs) were deter-
mined using a Bioscreen C (Labsystems, Helsinki, Finland).
The Bioscreen Microbial Growth Analyzer is a self-contained
microbial incubation and analysis unit that can evaluate
changes in turbidity of up to 200 samples (2  100 multi-
channel plates) over time, ranging from several hours to
several days. Antimicrobial dilutions were carried out as
described previously (Lambert et al., 1998) with modifications
SOR-LIFE H. A. Wright and B. F. Brehm-Stecher: Biomimetic antimicrobial systems
2
briefly explained for the enhancement with sesquiterpenoids.
In these assays, stock solutions were made into CAMHB
with final antimicrobial dilutions ranging from 125 mg/mL to
0.5 mg/mL. In combination assays with sesquiterpenoids,
stock solutions were again prepared in CAMHB with a final
sesquiterpenoid concentration of 100 mM. A set of control
wells was prepared for each experiment with CAMHB added
to the control wells to bring the final volume in all wells to the
same volume. The plates were incubated in the Bioscreen for
24 h at 30°C for bacteria and 35°C for yeasts and molds with
optical density measurements (600 nm) taken every 15 min
with shaking 10 sec prior. MICs were defined as the lowest
concentration of antimicrobial that completely inhibited
growth (OD increase ≤ 0.05) (Branen & Davidson, 2004).
Antimicrobial kinetics
The kinetics of antimicrobial killing was preformed to
measure the enhanced susceptibility of target culture cells to
antimicrobial agents in the presence of the sesquiterpenoids
and to quantify the speed and extent to which the inactivation
occurred. Polymers were added to overnight culture cells at
31.25 mg/mL with sesquiterpenoids being added to the system
at 200 mM. Aliquots were removed at certain time intervals
(0, 5, 10, 15, 30 min) for E. coli and (0, 30, 60 min) for C.
albicans with immediate dilution D/E (Dey/Engley) neutraliz-
ing broth (Becton Dickinson and Company, Franklin Lakes,
N.J.) to prevent residual effects of the antimicrobials. A 0.01 ml
aliquot of each dilution was track plated on D/E neutralizing
agar according to the guidelines of Jett et al. (1997) and
incubated for 24 h at 30°C or 35°C. Following incubation,
survival rates were based on survival comparisons to the
untreated bacterial control. D-values for treatments over time
were calculated from the survivor curves by plotting the
surviving population (log10) against antimicrobial treatments
at each time point. The equation of the best fit line was
obtained through linear regression analysis. The D-values
were determined as the interval of time required for the
survivor curve to provide a one decimal logarithm (1-log10)
or 90% reduction in the initial viable bacterial population
and are graphically equivalent to the negative inverse
slope of the regression line (Jay, 2005). Both surviving
population counts and D-values were analyzed using the
general linear model procedure of the SAS statistical soft-
ware (SAS Institute Inc., Cary, NC). Comparisons between
treatments were made by Tukey’s student range test
(p < 0.05).
D/E neutralization test
In order to verify that D/E agar was suitable for neutralizing
the activities of the polymers examined here, a D/E agar
neutralization test was performed according to the Difco and
BBL Manual of Microbiological Culture Media with modifica-
tions briefly described. Test organisms were grown overnight
and diluted in neutral phosphate buffer. An aliquot of the
bacterial culture was combined with a 0.7% agar overlay and
immediately poured over hardened D/E neutralizing agar. The
agar plates were swirled to ensure even distribution of the
test organism throughout the overlay. Sterile paper disks
(BBL, Becton Dickson and Company, Franklin Lakes, NJ) were
applied with the antimicrobial, placed on hardened agar
overlays, and incubated overnight. Zones of inhibition were
compared to zones seen on simultaneous tests of antimicro-
bial activity on CAMHA. D/E neutralizing agar exhibited no
zones of inhibition when compared to the activity on CAMHA,
suggesting that the antimicrobial activity was neutralized and
residual activity of the polymers upon plating was minimized.
Outer membrane permeabilization
Permeabilization of the outer membrane was determined by
a 1-N-phenylnaphthylamine (NPN) assay. E. coli cells were
centrifuged at 2000  g for 5 min and resuspended in neutral
phosphate buffer at 107 cfu/mL. Cells were placed in a 1-cm
cuvette, and changes in fluorescence were monitored with a
Cary Eclipse fluorometer (Varian) at an excitation wavelength
of 350 nm, an emission wavelength of 420 nm, and slit widths
of 5 nm. The background fluorescence was monitored for
10 sec before addition of NPN at a final concentration of 10
mM. PMX 50003 (31.25 mg/mL) and nerolidol (100 mM)
were tested alone and in combination for their ability to
permeabilize cells to NPN.
Transmission electron microscopy
For transmission electron microscopy (TEM)-based investiga-
tions of polymer effects on cellular ultrastructure, PMX 50003
was added to an overnight culture of Escherichia coli ATCC
25922 in CAMBH (~109 CFU/ml) at either 1 or 2 MIC
(31.25 mg ml or 62.5 mg ml, respectively), with or without
nerolidol added at 100 mM. These treatments (no-antimicrobial
control, nerolidol control, 50003 control, and nerolidol +
50003) were mixed thoroughly and aliquots were removed at
specific time intervals (0, 5, and 15 min). Upon removal,
aliquots were fixed with the addition of EM-grade glutaralde-
hyde (2.5% final concentration) and shipped to the University
of Iowa’s Central Microscopy Research Facility (Iowa City, IA)
for additional preparation prior to TEM.
RESULTS
Agar diffusion
Bisabolol, farnesol, and nerolidol enhanced the activity of all
three polymers tested against E. coli, S. aureus, and C. albicans,
with farnesol being the most effective enhancer. Nerolidol and
bisabolol showed similar enhancing potential at the levels
tested for all three organisms. When the sesquiterpenoids
were combined with the polymers, the lawns became less
dense compared to the controls for S. aureus (data not
shown). The addition of the sesquiterpenoids increased the
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zones of inhibition along with an overall general clearing of
the bacterial lawn. This could be evidence of slight intrinsic
antimicrobial activity that has been shown to be present in the
sesquiterpenes farnesol and nerolidol. Farnesol and nerolidol
have both previously been shown to reduce the initial S.
aureus viable cell load on a dose-dependent basis with the
proposed mechanisms being cell membrane damage (Inoue
et al., 2004).
Minimum inhibitory concentrations
MICs of the biomimetic antimicrobial polymers alone and in
combination with sesquiterpenoids are presented in Table 1.
Results of the negative controls containing either 1:1
methanol and water or propylene glycol at the highest final
concentration in the system indicated an absence of inhibi-
tion for all organisms tested (data not shown). All of the
polymers exhibited antimicrobial activity against the four
organisms tested with MICs ranging from 15.63 mg/mL to
62.5 mg/mL. The polymers alone were overall most effective
against the gram-positive S. aureus with 50003 exhibiting the
greatest antimicrobial activity with an MIC of 15.63 mg/mL.
The enhancement with sesquiterpenoids against S. aureus
was the greatest with farnesol, exhibiting a fourfold increase
in activity, whereas bisabolol and nerolidol each had a
threefold increase. PMX polymer 50001 had the same MIC
alone as PMX 50004; however, enhancement was not as
profound with 50001. All polymers had higher MIC values
against the yeast and mold, C. albicans and T. mentagro-
phytes, with enhancement by the sesquiterpenoids being
greater for T. mentagrophytes in all cases except for the
combination of 50003 and farnesol with C. albicans. The
lower MIC values for 50003 and increased enhancement in
the presence of the sesquiterpenoids as compared to 50001
highlight the potential importance of monomer composition
due to the only difference between these two butyl metha-
crylate polymers being their composition of monomers. This
could indicate the significance that different compositional
arrangements could play in both antimicrobial activity and in
the potential increased uptake by cells when combined in
formulations.
Antimicrobial kinetics
Kinetics of inactivation methods resulted in an immediate one
log reduction of E. coli growth when PMX 50003 was combined
with 200 mM nerolidol. Decimal reduction times were used
to indicate the rapid extent of combination on enhancing
antimicrobial activity (Table 2).
The combination of PMX 50003 and nerolidol had a D-value of
3.92 min compared to either 50003 (88.39 min) or nerolidol
(260.80 min) when assayed alone. After 5 min, there was a
significant difference in survivor counts between the combina-
tion polymer and nerolidol and either of the control polymer or
Table 1. Minimum inhibitory concentrations of PMX polymers and
enhancement by sesquiterpenoids against select microorganisms.
E. coli ATCC 25922
Minimum inhibitory concentration (µg/mL)
Sesquiterpenoid (100 µM)
Polymer Control + Bisabolol + Farnesol + Nerolidol
50001 31.25 15.63 7.81 15.63
50003 31.25 3.91 1.95 3.91
50004 62.5 3.91 3.91 3.91
S. aureus ATCC 25923
Minimum inhibitory concentration (µg/mL)
Sesquiterpenoid (100 µM)
Polymer Control + Bisabolol + Farnesol + Nerolidol
50001 31.25 15.63 3.91 15.63
50003 15.63 3.91 0.98 3.91
50004 31.25 3.91 0.98 3.91
C. albicans ATCC 90028
Minimum inhibitory concentration (µg/mL)
Sesquiterpenoid (100 µM)
Polymer Control + Bisabolol + Farnesol + Nerolidol
50001 62.5 31.25 31.25 31.25
50003 31.25 15.63 7.81 15.63
50004 62.5 31.25 31.25 31.25
T. mentagrophytes ATCC 9533
Minimum inhibitory concentration (µg/mL)
Sesquiterpenoid (100 µM)
Polymer Control + Bisabolol + Farnesol + Nerolidol
50001 62.5 15.63 15.63 31.25
50003 31.25 7.81 15.63 15.63
50004 62.5 15.63 15.63 31.25
Table 2. Enhancement of E. coli ATCC 25922 inactivation with
PMX polymer 50003 (31.25 µg/ml) and nerolidol (200 µM).
Survivor counts1 (log10 CFUml
−1)
per treatment time
Time (min) 0 5 10 15 30 D-value2 (min)
50003 8.75ab 8.69a 8.65a 8.64a 8.59a 88.39x
Nerolidol 8.83a 8.80a 8.79a 8.79a 8.77a 260.80y
50003 +
Nerolidol
8.21b 5.42b 4.85b 4.12b 3.99b 3.92z
1Survivor counts were reported as mean values of three replications.
2Decimal reduction time (D-value) is the unit time of exposure that
will results in a single log10 reduction in E. coli population.
a,bMicrobial counts at individual time points followed by the same
letter/s are not significantly different at (p > 0.05).
x,y,zD-values on the same row followed by the same letter/s are not
significantly different (p > 0.05).
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sesquiterpenoid alone. This significant difference remained
through the entire 30-min assay with a continued decrease in
survivor counts for the combination throughout (Figure 1).
Kinetics of inactivation with C. albicans showed similar trends;
however, the extent of inactivation was not measured over 60
min due to the slower inactivation of C. albicans at sub-
inhibitory concentrations with PMX 50004 (31.25 mg/mL).
The combination of 50004 and bisabolol caused a one log
reduction in survivor counts of C. albicans within 12.65 min
compared to 50004 (47.35 min) and bisabolol (122.55 min)
alone (Table 3).
The combination after 30 min was also significantly different
from the individual compounds indicating that the combina-
tion had increased activity over each component alone
(Figure 2).
Outer membrane permeabilization
NPN was used as an indicator of PM permeabilization. When
embedded in a more hydrophobic environment, the quantum
yield of NPN increases, making it an effective reporter of OM
damage. Components in the assay were added in a stepwise
sequential order to depict the impact of each compound on
OM permeabilization. This method showed that NPN alone
had some inherent fluorescence. Further addition of
Figure 1. Enhancement of E. coli ATCC 25922 inactivation with PMX polymer 50003. Time course kinetics with 50003 (31.25 µg/mL)
and enhancement with nerolidol (200 µM) sampled at 0, 5, 10, 15, and 30 min. Values for each time point having the same letter are
not signiﬁcantly different at p > 0.05.
Table 3. Enhancement of C. albicans ATCC 90028 inactivation
with PMX polymer 50004 (31.25 µg/ml) and bisabolol (200 µM).
Survivor counts1 (log10 CFUml
−1)
per treatment time
Time (min) 0 30 60 D-value (min)2
50004 6.93a 6.66a 6.38a 47.35xy
Bisabolol 7.03a 6.90a 6.75a 122.55x
50004 + Bisabolol 6.88a 5.41b 5.05b 12.65y
1Survivor counts were reported as mean values of three replications.
2Decimal reduction time (D-value) is the unit time of exposure that
will results in a single log10 reduction in C. albicans population.
a,bMicrobial counts at individual time points followed by the same
letter/s are not significantly different at (p > 0.05).
x,yD-values on the same row followed by the same letter/s are not
significantly different (p > 0.05).
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nerolidol only resulted in a slight increase in this baseline
fluorescence. When PMX 50003 was added alone with NPN,
permeabilization again was only marginally increased. Per-
meabilization occurred gradually over time and reached a
maximal value after 120 sec. The addition of NPN, followed
by 50003, and then nerolidol resulted in the same patterns of
fluorescence increase for NPN and 50003; subsequent addi-
tion of nerolidol resulted in a dramatic increase in fluores-
cence output (Figure 3).
The rapid cooperative interactions seen in the NPN uptake
assay were also observed via TEM, as shown in Figure 4.
DISCUSSION AND CONCLUSIONS
Microbial resistance
Emerging bacterial resistance to antimicrobial drugs repre-
sents a significant threat to human health. Market forces
affecting industrial R&D over the past 15 years have led to a
diminished pipeline for novel anti-infectives. This is especially
true for drugs targeting gram-negative bacteria, where new
agents capable of addressing hospital infections are not
expected to be available for another 10–15 years. This lack
of anti-infectives is particularly worrisome for emerging, drug-
resistant human pathogens, against which formerly useful, last
line-of-defense antimicrobials are no longer effective.
The traditional “one bug–one drug” concept may no longer be a
viable paradigm, given the broad nature of the antimicrobial
resistance threat. national institute of allergy and infectious
diseases (NIAID’s) agenda for future research includes plans to
promote discovery and development of natural antimicrobial
proteins, including defensins. AMPs, such as defensins, are
effective components of the host immune response and are
widely distributed throughout nature. Unfortunately, they are
expensive to produce in quantity, they are susceptible to
enzymatic or chemical degradation, and their structures and
activities are not easily manipulated. Nontoxic antimicrobial
polymers mimicking the structures of naturally occurring AMPs
such as those used here have been designed commercially as
novel therapeutics. Advantages of these compounds include
relatively simple and scalable syntheses, similar potencies as
their natural counterparts, and structural malleability that may
allow “fine tuning” of their antimicrobial activities or spectra.
The table below provides a comprehensive comparison of the
differences between natural AMPs versus biomimetic polymers
and the potential advantages of the latter.
Figure 2. Enhancement of C. albicans ATCC 90028 inactivation with PMX polymer 50004. Time course kinetics with 50004 (31.25 µg/
mL) and enhancement with bisabolol (200 µM) sampled at 0, 30, and 60 min. Values for each time point having the same letter are
not signiﬁcantly different at p > 0.05.
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Figure 3. NPN uptake assay with PMX 50003 and nerolidol using E. coli ATCC 25922. Time course of increase in NPN uptake with
50003 (31.25 µg/mL), nerolidol (200 µM) or the combination. NPN at 10 µM was added at 10 sec and allowed to stabilize before
addition of either nerolidol or 50003 at 30 sec. When used in combination, the second component was added at 50 sec. Enhanced
uptake of NPN was measured by an increase in ﬂuorescence, the result of partitioning of NPN into the outer membrane.
Figure 4. Sesquiterpenoid-mediated enhancement of PMX 50003 against E. coli ATCC 25922 via TEM. Panel A: control; Panel B: PMX
50003 (1× MIC), 15 min; Panel C: PMX 50003 (1× MIC) + 200 µM nerolidol, 5 min. Although PMX 50003 alone at 15 min exposure
caused some damage to cells, the combination of nerolidol and PMX 50003 led to severe damage (blebbing) after only 5 min. These
data provide evidence of cooperative interactions between nerolidol and this biomimetic polymer.
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This study demonstrates antimicrobial activities of biomimetic
polymers against a broad range of microorganisms. In addi-
tion, the enhancement effects of sesquiterpenoids, previously
proven effective in combination with clinically important
antibiotics (Brehm-Stecher & Johnson, 2003), have been
extended to include these polymers, leading to the production
of dramatically effective binary antimicrobial formulation. All
three polymers exhibited antimicrobial activity against both
gram-positive and gram-negative bacteria as well as against
fungi and molds, with substantial increases in activity demon-
strated in the presence of the three different sesquiterpenoids.
Additional experiments determined that the combination of
polymers and sesquiterpenoids significantly decreased initial
contact time necessary for the inhibition of growth when
compared to controls. Further analysis of the mechanisms of
action showed that penetration of the outer membrane was
increased in the presence of the sesquiterpenoids, pointing to
increased permeability as a mechanism for the increased
activity of the polymers when used in combination. These
combinations have the potential to yield high-activity anti-
microbial systems that have excellent promise for addressing
our dire need for methods to combat life-threatening bacterial
infections caused by organisms resistant to traditional anti-
microbials. Because our approach targets a generic and highly
conserved bacterial structure – the cell membrane – it is
unlikely that targeted microorganisms will be able to develop
additional resistance to this approach. The formulations
developed here may ultimately be of use both in clinical and
therapeutic applications and potentially in food-related appli-
cations, such as improved, wide-spectrum sanitizers.
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